Williams Cancer Institute

I was diagnosed with advanced prostate cancer in July 2018. After several high PSA readings, a biopsy and MRI were scheduled and revealed significant cancer in the prostate with a Gleason 3+4=7 score with extracapsular extension along with a lymph node abnormality. At the end of 2019 I consulted with a leading prostate cancer specialist who confirmed my cancer was metastatic and was not curable by approved standard of care treatments, including systemic immunotherapy because my cancer doesn’t possess the specific genetic mutations to make that viable. A few days later I consulted with Dr. Williams, who after reviewing all my medical records determined I was a candidate for intratumoral immunotherapy.